Ana María Rojas-Gómez
Ana María Rojas-Gómez has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Francisca Verdugo-Paiva
Center for Integrative Global Oral Health, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA
6 shared publications - Gabriel Rada
Pontificia Universidad Católica de Chile
4 shared publications - Alonso Carrasco-Labra
Department of Preventive and Restorative Sciences, Penn Dental Medicine University of Pennsylvania Philadelphia Pennsylvania USA
2 shared publications - Ana Maria Castillo
Keralty Global Institute for Health Care Excellence (IGEC-K), Bogotá 110111, Colombia
2 shared publications - Andrea Bermudez-Rodriguez
Models and Programs Unit, Keralty Global Institute for Health Care Excellence (IGEC-K), Bogotá 110111, Colombia
2 shared publications - Ankita Shashikant Bhosale
Center for Integrative Global Oral Health, School of Dental Medicine, University of Pennsylvania, Philadelphia, PA
2 shared publications
Latest Publications
- Open Access
- 26 June 2026
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 23 (7) , 840
Implicit Bias in Health Professionals: A Scoping Review
Implicit bias, automatic attitudes or stereotypes outside conscious awareness, may influence clinicians’ communication, diagnosis, and treatment decisions, contributing to inequities in care. We conducted a scoping review to map measurement strategies used to assess implicit bias among health professionals and students in healthcare and training settings. Using Joanna Briggs Institute guidance and PRISMA-ScR, we searched PubMed, Embase, BVS, Google Scholar, and institutional repositories for studies to November 2025; two reviewers independently screened and charted data (protocol was developed a priori but submitted internal in organization, and then uploaded in OSF. Of 1864 records, 93 studies from 28 countries were included. We identified 57 bias domains, most often race/ethnicity, weight, and sexual orientation. Across studies, 42 unique instruments were reported; the Implicit Association Test was most common, while psychometric validation and administration details were frequently limited, constraining comparability and interpretation. Evidence gap mapping showed concentration in academic and hospital settings, with fewer studies in primary care or community contexts and limited attention to age, disability, and intersectionality-related biases. The evidence base is growing but fragmented; future work should prioritize standardized administration and reporting, stronger validation, and tools that better capture automatic responding across diverse identities and care settings to support education and equity-oriented interventions.
- 26 June 2026
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 23 (7) , 840
Open AccessImplicit Bias in Health Professionals: A Scoping Review
Implicit bias, automatic attitudes or stereotypes outside conscious awareness, may influence clinicians’ communication, diagnosis, and treatment decisions, contributing to inequities in care. We conducted a scoping review to map measurement strategies used to assess implicit bias among health professionals and students in healthcare and training settings. Using Joanna Briggs Institute guidance and PRISMA-ScR, we searched PubMed, Embase, BVS, Google Scholar, and institutional repositories for studies to November 2025; two reviewers independently screened and charted data (protocol was developed a priori but submitted internal in organization, and then uploaded in OSF. Of 1864 records, 93 studies from 28 countries were included. We identified 57 bias domains, most often race/ethnicity, weight, and sexual orientation. Across studies, 42 unique instruments were reported; the Implicit Association Test was most common, while psychometric validation and administration details were frequently limited, constraining comparability and interpretation. Evidence gap mapping showed concentration in academic and hospital settings, with fewer studies in primary care or community contexts and limited attention to age, disability, and intersectionality-related biases. The evidence base is growing but fragmented; future work should prioritize standardized administration and reporting, stronger validation, and tools that better capture automatic responding across diverse identities and care settings to support education and equity-oriented interventions.
- Open Access
- 2 June 2026
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 157 (9) , 980-992
Light-based adjuncts to determine the need for biopsy for early detection of oral squamous cell carcinoma and potentially malignant disorders
- 2 June 2026
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 157 (9) , 980-992
Open AccessLight-based adjuncts to determine the need for biopsy for early detection of oral squamous cell carcinoma and potentially malignant disorders
- Open Access
- 6 April 2026
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 157 (6) , 588-601
Vital staining adjuncts to determine the need for biopsy for early detection of oral squamous cell carcinoma and potentially malignant disorders
- 6 April 2026
- Published by Elsevier in The Journal of the American Dental Association
- Vol. 157 (6) , 588-601
Open AccessVital staining adjuncts to determine the need for biopsy for early detection of oral squamous cell carcinoma and potentially malignant disorders
- Open Access
- 10 March 2026
- Published by MDPI AG in Preprints.org
Implicit Bias in Health Professionals: A Scoping Review
Implicit bias, automatic attitudes or stereotypes outside conscious awareness, may influence clinicians’ communication, diagnosis, and treatment decisions, contributing to inequities in care. We conducted a scoping review to map measurement strategies used to assess implicit bias among health professionals and students in healthcare and training settings. Using Joanna Briggs Institute guidance and PRISMA-ScR, we searched PubMed, Embase, BVS, Google Scholar, and institutional repositories for studies to November 2025; two reviewers independently screened and charted data (protocol was developed a priori but submitted internal in organization, and then uploaded in OSF ). Of 1,864 records, 93 studies from 28 countries were included. We identified 57 bias domains, most often race/ethnicity, weight, and sexual orientation. Across studies, 42 unique instruments were reported; the Implicit Association Test was most common, while psychometric validation and administration details were frequently limited, constraining comparability and interpretation. Evidence gap mapping showed concentration in academic and hospital settings, with fewer studies in primary care or community contexts and limited attention to age, disability, and intersectionality-related biases. The evidence base is growing but fragmented; future work should prioritize standardized administration and reporting, stronger validation, and tools that better capture automatic responding across diverse identities and care settings to support education and equity-oriented interventions.
- 10 March 2026
- Published by MDPI AG in Preprints.org
Open AccessImplicit Bias in Health Professionals: A Scoping Review
Implicit bias, automatic attitudes or stereotypes outside conscious awareness, may influence clinicians’ communication, diagnosis, and treatment decisions, contributing to inequities in care. We conducted a scoping review to map measurement strategies used to assess implicit bias among health professionals and students in healthcare and training settings. Using Joanna Briggs Institute guidance and PRISMA-ScR, we searched PubMed, Embase, BVS, Google Scholar, and institutional repositories for studies to November 2025; two reviewers independently screened and charted data (protocol was developed a priori but submitted internal in organization, and then uploaded in OSF ). Of 1,864 records, 93 studies from 28 countries were included. We identified 57 bias domains, most often race/ethnicity, weight, and sexual orientation. Across studies, 42 unique instruments were reported; the Implicit Association Test was most common, while psychometric validation and administration details were frequently limited, constraining comparability and interpretation. Evidence gap mapping showed concentration in academic and hospital settings, with fewer studies in primary care or community contexts and limited attention to age, disability, and intersectionality-related biases. The evidence base is growing but fragmented; future work should prioritize standardized administration and reporting, stronger validation, and tools that better capture automatic responding across diverse identities and care settings to support education and equity-oriented interventions.
- Open Access
The Epistemonikos Database of Trials: A Comprehensive and Freely Accessible Bibliographic Source of Randomized Trials in Health
Randomized controlled trials (RCTs) are the cornerstone of evidence-based healthcare, providing the most reliable means of assessing the efficacy and safety of health interventions. However, their rapidly growing volume and dispersion across diverse sources, such as bibliographic databases, preprint servers, and trial registries, pose major challenges for evidence synthesis, clinical guideline development, and health technology assessment. Despite longstanding recognition of their importance and multiple initiatives to improve accessibility, there is still no comprehensive, freely available, and continuously updated resource of trial records. To address this gap, the Epistemonikos Foundation developed the Epistemonikos Database of Trials (ED-Trials), a continuously updated repository of RCTs identified from more than 30 sources, including bibliographic databases, preprint servers, international trial registries, and other search sources. This paper describes the methods used to identify and classify trial records, outlines the key features of the search interface, and reports the database status as of October 2025. ED-Trials now includes more than 1.5 million unique trial records, many of which are not indexed in MEDLINE or other conventional bibliographic databases. It represents a significant scholarly and technical achievement, offering a freely accessible and user-friendly resource that enables more efficient, comprehensive, and up-to-date identification of randomized controlled trials, thereby strengthening the foundation of evidence-based healthcare.
Open AccessThe Epistemonikos Database of Trials: A Comprehensive and Freely Accessible Bibliographic Source of Randomized Trials in Health
Randomized controlled trials (RCTs) are the cornerstone of evidence-based healthcare, providing the most reliable means of assessing the efficacy and safety of health interventions. However, their rapidly growing volume and dispersion across diverse sources, such as bibliographic databases, preprint servers, and trial registries, pose major challenges for evidence synthesis, clinical guideline development, and health technology assessment. Despite longstanding recognition of their importance and multiple initiatives to improve accessibility, there is still no comprehensive, freely available, and continuously updated resource of trial records. To address this gap, the Epistemonikos Foundation developed the Epistemonikos Database of Trials (ED-Trials), a continuously updated repository of RCTs identified from more than 30 sources, including bibliographic databases, preprint servers, international trial registries, and other search sources. This paper describes the methods used to identify and classify trial records, outlines the key features of the search interface, and reports the database status as of October 2025. ED-Trials now includes more than 1.5 million unique trial records, many of which are not indexed in MEDLINE or other conventional bibliographic databases. It represents a significant scholarly and technical achievement, offering a freely accessible and user-friendly resource that enables more efficient, comprehensive, and up-to-date identification of randomized controlled trials, thereby strengthening the foundation of evidence-based healthcare.
- 28 September 2022
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 38 (1) , e73
Nonsurgical periodontal treatment in type II diabetics in a middle-income country: a cost-effectiveness analysis
Objectives: To evaluate the cost-effectiveness of the nonsurgical periodontal treatment (NSPT) compared with supragingival therapy in type II diabetics with periodontitis. Methods: A decision tree analysis was used to estimate the costs and health outcomes of two periodontal therapies in a hypothetical cohort of type II diabetics with periodontitis. The analysis was developed from the perspective of a third-party payer at 1 year and 5 years. Probabilities were derived from two systematic reviews. The costs and resource use were validated by a Delphi expert panel. All costs were expressed in USD, using the 25 May 2021 Colombian pesos market exchange rate (USD 1 = COP 3,350). Results: NSPT was a dominant alternative compared with subsidized supragingival therapy in type II diabetics with periodontitis, generating savings of USD 87 and 400, during the first year or up to 5 years, respectively, and improving dental survival from 32 to 69 percent. Conclusions: NSPT can generate savings by reducing the complications derived from uncontrolled periodontitis and tooth loss.
- 28 September 2022
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 38 (1) , e73
Nonsurgical periodontal treatment in type II diabetics in a middle-income country: a cost-effectiveness analysis
Objectives: To evaluate the cost-effectiveness of the nonsurgical periodontal treatment (NSPT) compared with supragingival therapy in type II diabetics with periodontitis. Methods: A decision tree analysis was used to estimate the costs and health outcomes of two periodontal therapies in a hypothetical cohort of type II diabetics with periodontitis. The analysis was developed from the perspective of a third-party payer at 1 year and 5 years. Probabilities were derived from two systematic reviews. The costs and resource use were validated by a Delphi expert panel. All costs were expressed in USD, using the 25 May 2021 Colombian pesos market exchange rate (USD 1 = COP 3,350). Results: NSPT was a dominant alternative compared with subsidized supragingival therapy in type II diabetics with periodontitis, generating savings of USD 87 and 400, during the first year or up to 5 years, respectively, and improving dental survival from 32 to 69 percent. Conclusions: NSPT can generate savings by reducing the complications derived from uncontrolled periodontitis and tooth loss.
- Open Access
- 26 February 2022
- Published by Elsevier in American Journal of Infection Control
- Vol. 50 (12) , 1381-1388
Effects of screening strategies to detect carbapenem-resistant gram-negative bacteria: A systematic review
- 26 February 2022
- Published by Elsevier in American Journal of Infection Control
- Vol. 50 (12) , 1381-1388
Open AccessEffects of screening strategies to detect carbapenem-resistant gram-negative bacteria: A systematic review
- Open Access
COVID-19 L·OVE REPOSITORY IS HIGHLY COMPREHENSIVE AND CAN BE USED AS A SINGLE SOURCE FOR COVID-19 STUDIES
Objective COVID-19 Living OVerview of Evidence (COVID-19 L·OVE) is a public repository and classification platform for COVID-19 articles. The repository contains over 430,000 articles as of 20 September 2021 and intends to provide a one-stop shop for COVID-19 evidence. Considering that systematic reviews conduct high-quality searches, this study assesses the comprehensiveness and currency of the repository against the total number of studies in a representative sample of COVID-19 systematic reviews. Methods Our sample was generated from all the studies included in the systematic reviews of COVID-19 published during April 2021. We estimated the comprehensiveness of COVID-19 L·OVE repository by determining how many of the individual studies in the sample were included in the COVID-19 L·OVE repository. We estimated the currency as the percentage of studies that were available in the COVID-19 L·OVE repository at the time the systematic reviews conducted their own search. Results We identified 83 eligible systematic reviews that included 2132 studies. COVID-19 L·OVE had an overall comprehensiveness of 99.67% (2125/2132). The overall currency of the repository, that is, the proportion of articles that would have been obtained if the search of the reviews was conducted in COVID-19 L·OVE instead of searching the original sources, was 96.48% (2057/2132). Both the comprehensiveness and the currency were 100% for randomised trials (82/82). Conclusion The COVID-19 L·OVE repository is highly comprehensive and current. Using this repository instead of traditional manual searches in multiple databases can save a great amount of work to people conducting systematic reviews and would improve the comprehensiveness and timeliness of evidence syntheses. This tool is particularly important for supporting living evidence synthesis processes
Open AccessCOVID-19 L·OVE REPOSITORY IS HIGHLY COMPREHENSIVE AND CAN BE USED AS A SINGLE SOURCE FOR COVID-19 STUDIES
Objective COVID-19 Living OVerview of Evidence (COVID-19 L·OVE) is a public repository and classification platform for COVID-19 articles. The repository contains over 430,000 articles as of 20 September 2021 and intends to provide a one-stop shop for COVID-19 evidence. Considering that systematic reviews conduct high-quality searches, this study assesses the comprehensiveness and currency of the repository against the total number of studies in a representative sample of COVID-19 systematic reviews. Methods Our sample was generated from all the studies included in the systematic reviews of COVID-19 published during April 2021. We estimated the comprehensiveness of COVID-19 L·OVE repository by determining how many of the individual studies in the sample were included in the COVID-19 L·OVE repository. We estimated the currency as the percentage of studies that were available in the COVID-19 L·OVE repository at the time the systematic reviews conducted their own search. Results We identified 83 eligible systematic reviews that included 2132 studies. COVID-19 L·OVE had an overall comprehensiveness of 99.67% (2125/2132). The overall currency of the repository, that is, the proportion of articles that would have been obtained if the search of the reviews was conducted in COVID-19 L·OVE instead of searching the original sources, was 96.48% (2057/2132). Both the comprehensiveness and the currency were 100% for randomised trials (82/82). Conclusion The COVID-19 L·OVE repository is highly comprehensive and current. Using this repository instead of traditional manual searches in multiple databases can save a great amount of work to people conducting systematic reviews and would improve the comprehensiveness and timeliness of evidence syntheses. This tool is particularly important for supporting living evidence synthesis processes
- Open Access
- 1 April 2021
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in International journal of interdisciplinary dentistry
- Vol. 14 (1) , 105-109
Infiltración de resina y barniz de flúor para el tratamiento de caries interproximales no cavitadas en dentición permanente.
PALABRAS CLAVE: Caries; Infiltración de resina; Caries interproximal; Barniz de flúor; Tratamiento mínimamente invasivo; Epistemonikos; GRADE
- 1 April 2021
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in International journal of interdisciplinary dentistry
- Vol. 14 (1) , 105-109
Open AccessInfiltración de resina y barniz de flúor para el tratamiento de caries interproximales no cavitadas en dentición permanente.
PALABRAS CLAVE: Caries; Infiltración de resina; Caries interproximal; Barniz de flúor; Tratamiento mínimamente invasivo; Epistemonikos; GRADE